Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
ESPEN Congress Florence 2008
Nutritional consequences of cancer therapy
Continued nutritional support and monitoring in
cancer
F. Strasser (Switzerland)
Florian Strasser ESPEN 2008
ESPEN 2008 Saturday, 13th September 2008 14:30 – 16:00
Educational session – joint with ESMO
Nutritional consequences of cancer therapy
Continued nutritional support and
monitoring in cancer
Florian Strasser, MD ABHPM
Oncological Palliative Medicine
Cantonal Hospital, St. Gallen, Switzerland
Member of the Palliative Care Working Group of ESMO
ESPEN 2008 Saturday, 13th September 2008 14:30 – 16:00
Educational session – joint with ESMO
Nutritional consequences of cancer therapy
Continued nutritional support and
monitoring in cancer
Florian Strasser ESPEN 2008
Prevention of cancer
through nutritionMalnutrition as risk-factor for
(curative) anticancer
treatments (Chemotherapy,
Surgery, Radiotherapy)
Malnutrition as consequence of
complications of anticancer treatments
(bowel function, mucositis, infections, ...)
Malnutrition in advanced, incurable cancer:
multimodal nutritional interventions for
complex nutritional problems
Terminal care: changed importance of nutrition
Nutritional issues in the trajectory of
cancer illness
Phasen der Erkrankung
Florian Strasser ESPEN 2008
Fluctuating trajectories of illness
Information,
communication
Distress
psychosocial
Autonomy,
Decisions
Distress
physicalIndividual patient trajectories
Diagnosis Progression (s) End-of-LifeComplication (s)
In modern oncology (phases of progression, response,
and treatments) cachexia„s importance fluctuates
Florian Strasser ESPEN 2008
Auswirk-xct
Weight loss / Malnutrition: independent prognost.
Factor- Survival: Locally advanced esophageal cancer
- Survival: Lung cancer
- Treatment-response, Survival: advanced Head-and-Neck cancer
- ... Many other examples
Stahl M, et al.. J Cancer Res Clin Oncol 2004, Oct 5 [Epub ahead of print].
Tammemagi CM, et al. Cancer 2004;101(7):1655-63.
Argiris A, Li Y, Forastiere A. Cancer 2004;101(10):2222-9.
Nutritional complications in patients with
advanced cancer are frequent and matter
Florian Strasser ESPEN 2008
Cachexia Management: Current Clinical Dilemmas
Neglected Overtreatment
„Aggressive“parenteral
nutrition lacking
achievable goals4
Narrow & short effect of
progestin, corticosteroids5
Pressure (family, patient)
preserving the normal6
Problem not recognized1
Silent Malnutrition Epidemia2
Simple starvation overlooked3
Lack of clinical-guiding
definition and staging system
Poor effect of interventions5
1: Spiro A et al. The views and practice of oncologists towards nutritional support in patients
receiving chemotherapy. Br J Cancer 2006;95:431-4; 2: European Prospective Investigation into
Cancer and Nutrition; 3: Omlin AG, Strasser F. Secondary causes of cancer-related anorexia:
Recognition in daily practice [..]. ASCO 2007; 4: Bozzetti F. Total parenteral nutrition in cancer
patients. Curr Opin Support Palliat Care 2007;1:281-6; 5: Yavuszen et al. J Clin Oncol 2005;23:8500-
11; 6: Strasser F et al. Palliative Medicine 2007;21:129-37.
Florian Strasser ESPEN 2008
Detect patients nutritional
issues in daily care
Perform a „nutritional“
staging: domains
„Nutritional“ support – continued after
chemotherapy and radiotherapy
Setting „nutritional“ goals
in palliative cancer care
Alleviate burden of
cachexia and symptoms
Florian Strasser ESPEN 2008
In the absence of simple starvation, cancer
cachexia is diagnosed by weight loss >5% over the
last 6 months. Weight loss should be ongoing in
the last 1 – 2 months.
In patients with significant fluid retention, large tumor
mass or obesity (BMI >30kg/m2) significant muscle
wasting may occur in the absence of weight loss. In
such patients a direct measure of muscularity is
recommended.
Detect patients nutritional issues in daily care:
Weight loss
Clinical Cachexia Expert consensus,
ongoing Delphi procedure
Mid-arm circumference, BIA (?), DEXA, L4-CT-scan
Florian Strasser ESPEN 2008
Detect patients nutritional issues in daily care:
Screening in daily care – implement locally
Then:
How much
percent of
your
normal
oral intake
you take in
now?
Look at
plates !
Florian Strasser ESPEN 2008
Perform a „nutritional“ staging
Domains of cancer cachexia
The following key components are of high value for
clinical assessment of cancer cachexia:
● Anorexia/ ▼food intake (central, chemosensory, gut)
● Catabolic drive (Tumor, Inflammation, Hypogonadism)
● Decreased muscle mass and strength
● Impact of cachexia (Distress, Physical function)
● Other factors (e.g. anemia, loss of fat mass)
Clinical Cachexia Expert consensus,
ongoing Delphi procedure
Florian Strasser ESPEN 2008
Specific
symptoms &
complications
impacting
nutrition
Nausea
Vomiting
Constipation
Diarrhea
Defecation after meal
Pain
Dyspnoea
Fatigue
Anxiety/depression
Sense of hopelessness
Stomatitis
Dysgeusia
Dental problems
Difficulty chewing
Dysosmia
Xerostomia
Thick saliva
Dysphagia
Epigastric pain
Abdominal pain
Many frequent symptoms and complications in
Palliative Cancer Care can contribute to Cachexia
Perform a „nutritional“ staging
„Simple starvation“
Florian Strasser ESPEN 2008
Normal
Survival
Pre-cachexia Cachexia syndrome Advanced cachexia
Death
Subtle loss metabolic/endocrine
change
Weight loss Reduced food intake
Systemic inflammation
Severe muscle wasting Fat loss
Immunocompromised
< 3 months? 3 – 9 months? > 6-9 months?
Fearon K. Eur J Cancer
2008; 2008;44,1124-32
Cancer cachexia is a spectrum from early to late.
Not all patients will progress down the spectrum.
Clinical Cachexia Expert consensus,
ongoing Delphi procedure
Perform a „nutritional“ staging
Stages
Florian Strasser ESPEN 2008
Patients with late, severe, cancer cachexia have
advanced muscle wasting (+ - loss of fat).
Patients have a low performance status and it is
evident that the burden of artificial nutritional
support would out-weigh any potential benefits, the
prognosis of survival is too short to reverse
depletion.
Therapeutic interventions focus typically on
alleviating the consequences/complications of
cachexia, e.g. psychosocial eating-related distress.
Clinical Cachexia Expert consensus,
ongoing Delphi procedure
Perform a „nutritional“ staging
Late stage
Florian Strasser ESPEN 2008
Symptoms in cachexia assessment:
„A family of distinct characters“
A Symptoms mirroring the pathogenesis of cachexiaEarly satiety, appetite loss, no desire to eat, weakness
B Symptoms & syndromes causing simple starvation
Pain, vomiting, dyspnea,
C Symptoms reflecting the impact of cachexia
Fatigue, eating-related distress
Perform a „nutritional“ staging
Symptoms
Florian Strasser ESPEN 2008
Ed2 Assess – Step1
Body Mass Index: actual kg/cm2
Weight loss: kg before 2 & 6 mts
Nutritional intake: % reduction pat. estimate
Symptom: subjective loss of appetite
(nausea, early satiety, etc.)
Tumor: Catabolic drive, CRP?
Function: Physical functioning
Pat. & Relatives: eating-related distress
kg/cm, kg , ,
Perform a „nutritional“ staging
Simple (?) staging in practice
Florian Strasser ESPEN 2008
Assessment tool to guide management of patients
with cancer cachexia
Stores Amount of depletion, prognosis
Intake Central, taste, smell, gut dysmotility
Simple starvation – secondary causes
Potential Cancer control (chance), inflammation
Performance Physical function, distress
Screening tool: weight loss, physical function
Outcomes for clinical anti-cachexia treatment trials:
muscle strenght (handgrip), muscle mass, function, other
Perform a „nutritional“ staging
Future: Cancer Cachexia Assessment System
Florian Strasser ESPEN 2008
Detect patients nutritional
issues in daily care
Perform a „nutritional“
staging: domains
„Nutritional“ support – continued after
chemotherapy and radiotherapy
Setting „nutritional“ goals
in palliative cancer care
Alleviate burden of
cachexia and symptoms
Florian Strasser ESPEN 2008
Case 1/3
61-y man, cardia-carcinoma (uT3 uN1 M1)
Metastasis:liver, peritoneal, gluteal, bones
Day 1 second cycle chemotherapy (ECF)
45 kg, 2 mts ago 51 kg, 164 cm, BMI 19.6, oral
intake 25% of normal, appetite 5/10
Stomatitis G1, h/o abd. Surgery, CRP 21 g/dl
Early satiety 6/10, nausea 4/10, dysphagia
1/10, fatigue 8/10, abdominal pain 3/10
Wife distressed what to cook, wants TPN
Acetaminophen, novamine, osmotic laxative
How do YOU manage a patient in your practice?
Florian Strasser ESPEN 2008
Setting „nutritional“ goals in
palliative cancer care
Screen for symptom, check impact, prioritize
Cause-directed
treatments if
reversible, and
treatment
appropriate
Alleviate
suffering from
multi-
dimensional
consequences
Empower
patient and
family to
understand
cachexia
Diagnosis and multidimensional assessment of
cachexia and its impact: far more than weight loss
Florian Strasser ESPEN 2008
Ed10.1 Best Tx Step 6
rarely
rarely
Zinc
div.
SSRI
short
short
short
short
short
short
Nutritional Interventions
Prokin
etics
Cortic
ost.
Proges
tine
Other
drugs.
Suppl.
iv, oral
Couns
Team
Effect likely
Effect possible - uncertain
No effect
Setting „nutritional“ goals
Which „nutritional“ intervention for which goal?
Loss of weight - survival
Loss of appetite
Oral intake
Body composition, BMI
- Edema
Physical function
Quality of life
- Fatigue - Asthenia
- Early satiety
- Nausea
- Taste problems
- Dyspnea
Psychosocial distress
Existential distress
Florian Strasser ESPEN 2008
Pharmacological anti-cachexia treatments*
Increase of nutritional intake: oral, enteral, TPN
Relieve eating-related distress
Decide on physical activity interventions
Reversibility of cachexia: go for anticancer
treatment
Balance priorities in advanced cancer care(symptoms, family, use limited time, …)
* Yavuszen et al., JCO 2006; Strasser F. Curr Opinion Supp Pall Care, 12.2007
Setting „nutritional“ goals
Multidimensional nutritional interventions
Florian Strasser ESPEN 2008
Ed5.2 TPN example
Progestins:
Presence of anorexia: symptom alleviation
Body weight: improve body „image“ (fat, water)
Berenstein & Ortiz. Cochrane Database Syst Rev 2005;(2):CD004310.
Multidimensional nutritional interventions
Established pharmacological treatments
Prokinetics:
Presence of early satiety, chronic nauses
Corticosteroids:
Overall “well-being” boost if “inflammation”
Florian Strasser ESPEN 2008
Corticosteroids
20 bis 50 mg Prednisolon-Aequivalent for 1 to 2 weeks
Appetite, Nausea, Fatigue, Wellbeing short (!) better
After 3-4 Weeks: Myopathy, Infect., Insuline resistance
Progestins
Megestrol acetate (Megestat 2-4 x 160mg) or
Medroxyprogesteron acetate (Farlutal 800mg)
appetite better after 4-7 days, price, thromboembolism 5%
Prokinetics
Metoclopramid 10 - 15 mg 30 Min before meals, or
Domperidon (Motilium), ev. tegaserod
Early satiety, chronic Nausea; Extrapyramidal AE
Yavuszen et al., JCO 2006 Strasser F, Bruera ED. Hematol Oncol Clin North Am 2002;16:589-617.
Etabl. Pharmak. Th ACS
Multidimensional nutritional interventions
Established pharmacological treatments: Dose ..
Florian Strasser ESPEN 2008
Multidimensional nutritional interventions
Increasing nutritional intake
Various forms of nutritional „support“3
Conscious control of eating1
Individual counseling2
Oral supplements2
Enteral nutrition
Parenteral nutrition4
1: Shragge J et al., submitted
2: Ravasco P et al. J Clin Oncol 2005; 23:1431-8
3: Stratton RJ, Elia M: Eur J GE Hep 2007;19:353-8
4: Hoda D et al., Cancer 2005;103:863
Florian Strasser ESPEN 2008
Assess and improve intake of calories and protein
Assess patients„ individual eating habits
Check frequencies of daily meals1
Empower patients to change their daily habits
Help patients and family members to understand
(early satiety, no hunger, taste changes, etc.)
Multidimensional nutritional interventions
Nutritional counselling
1: Alberta nutrtition group 2008
Florian Strasser ESPEN 2008
Few studies supporting clearly effectivityStratton et al., Clin Nutr 1999
Mixed population including cancer patients
Supplements
Tolerability of oral supplements in patients with
advanced cancer poor (taste, aversion, ..)
Taste and smell problems frequent
Bernhardson et al. Self-reported taste and smell changes during cancer chemotherapy. Support
Care Cancer 2007 Aug 21
Hutton et al. Chemosensory dysfunction is a primary factor in the evolution of declining
nutritional status and quality of life in patients with advanced cancer. J Pain Symptom
Manage 2007;33:156
Multidimensional nutritional interventions
Increasing nutritional intake: oral supplements
BUT: NS are important in individualized daily care
Florian Strasser ESPEN 2008
In pts having catabolic metabolism (active
cancer), “artificial” increase of kaloric (nutritional)
intake is inefficient, and causes adverse effects.
Ed6 - TPN unselected
VA TPN Clin Study Group NEJM 1991:325:525
Bozzetti F, et al. Nutrition 12(3):163-7,1996
Klein S, et al. Am J Clin Nutrition 66,683-706, 1997
Torelli GF et al. Nutrition 15(9):665-7,1999
Winter SM. Am J Med 109(9):723-6, 2000
Many studies confirm in-effectivity of TPN:
- adjunctive to chemotherapy or radiotherapy
- Cachectic pts with “intact” bowel function
Multidimensional nutritional interventions
Increasing nutritional intake: Parenteral Nutrition
Florian Strasser ESPEN 2008
Ed5.2 TPN example
Duerksen DR et al. Is there a role for TPN in
terminally ill patients with bowel obstruction?
Nutrition. 2004 Sep;20(9):760-3. N=9
Home parenteral nutrition studies
Multidimensional nutritional interventions
Increasing nutritional intake: Parenteral Nutrition
Florian Strasser ESPEN 2008
Elements of eating-related distress1
● Contra-intuitive, unpredictable inability to eat and weight loss
● Existential distress (loss of weight and control)
● Change of cooking habits, cooking as expression of love
● Couples coping: trying, searching advice, pressure, accept
Item-bank development for assessment
1 Strasser F et al. Palliative Medicine 2007;21:129-37
Emerging awareness of psychosocial consequences
of cachexia: 12 papers identified in systematic
literature review2, EAPC 2008
Multidimensional nutritional interventions
Alleviate psychosocial distress related to eating
Florian Strasser ESPEN 2008
Anti-neoplastic interventions
may contribute to stabilization of weight loss and
anorexia (several data: pancreatic ca., NSCLC, CRC,..)
But nutritional intake NOT measured
Antineopl
Multidimensional nutritional interventions
Improve cancer-caused catabolism and anorexia
Or do they cause muscle wasting? [taxans]
Is neuromuscular dysfunction contributing to muscle
loss?
Florian Strasser ESPEN 2008
Cachexia is one among other problems: prioritize
• Pain-Syndromes (80%)
• Fatigue (90%)
• Loss of Appetite & Weight (80%)
• Nausea / Vomiting (90%)
• Anxiety (25%)
• Shortness of Breath (50%)
• Delirium-Agitation (80%)
• Depressive Symptoms (30%)
• Social / Family Distress (>30%)
• Existential Distress (>30%)
Teunisen & Graeff, EAPC 2007. Volume 4 Topics Pall Care. Walsh D Supp Care Cancer 2000. Vainio A
J Pain Symp Manag 1996. Reuben DB Arch Intern Med 1988. Dewys WD Am J Med 1980
Cachexia causes (also) symptom interactions
• Pain-Syndromes (80%)
• Fatigue (90%)
• Loss of Appetite & Weight (80%)
• Nausea / Vomiting (90%)
• Anxiety (25%)
• Shortness of Breath (50%)
• Delirium-Agitation (80%)
• Depressive Symptoms (30%)
• Social / Family Distress (>30%)
• Existential Distress (>30%)
Multidimensional nutritional interventions
Multidimensional aspects of suffering
Florian Strasser ESPEN 2008
Cachexia involves typically the „whole“ family
Family members are partners
in care, involved in nursing,
organisation, enhancing
compliance (and pressure), …
Family members are suffering from losses, role
change, misunderstandings, etc.
Multidimensional nutritional interventions
Unity of care involving families in care concepts
Florian Strasser ESPEN 2008
Goals Palliative Care
● Self efficacy
● Sense of coherence
● Security
● Support families
Competencies
● Symptom management
● Decision making
● Networking support
● Caregivers counselling
1
Is Cachexia
important?
Multidimensional nutritional interventions
Priorities in advanced cancer care
Florian Strasser ESPEN 2008
Cachexia assessment requires acknowledgment
of multidimensional aspects.
Specialized approaches („cachexia“
clinics1,2) consist of multi-diciplinary
teams covering nutritional, psycho-
social-spiritual, physical, medical,
and nursing aspects (among other)
Cachexia assessment & management is teamwork
1 Dalal S, et al., EAPC 2008 #396; 2 Strasser F et al, ESMO 2006
2
Multidimensional nutritional interventions
Delivery of care by multi-professional teams in
various care settings
Florian Strasser ESPEN 2008
Current approach (St.Gallen Nutrition & Fatigue Clinic)
● ESAS
● MMSQ
● HADS
● SACS*
● SIF*
● 2-d oral intake
● Diet type
● Social net
● FICA*
● Coping
● ERD*
● Function: FIM
● Preferred PA*
SACS: secondary anorexia & cachexia checklist; SIF: single-item fatigue
domains; ERD: eating related-distress; PA: physical activities; FICA: Faith
Interventions: nutritional, anti-
cachexia drugs, counselling
(understanding, calman-gap,
meaning), secondary anorexia
treatment, physical activity,
oncological, social net.
Florian Strasser ESPEN 2008
Screen ALL patients for nutritional problems
(weight, kcal, anorexia, BMI+, fatigue, distress, ..
Identify and treat secondary anorexia/cachexia
(different causes in trajectory of illness)
Estimate primary anorexia/cachexia:
catabolic drive: inflammation (CRP) – tumor (assess)
If give additional nutrition: monitor goals and
adverse events (incl. distress, wrong priorities)
Work in an interdisciplinary team, cultivate
multidimensional professional care (alternative Tx)
Conclusion
Nutrition: To do or not to do?
Conclusions – take home
Florian Strasser ESPEN 2008
Florian Strasser ESPEN 2008
Cancer Cachexia close to End-of-Life
Does cachexia – a normal feature of dying - hurt?
EXPECTATIONS
STATUS
Function
or
eating
or
other
TIME
Status - Expect
Calman gap1:
difference of
expectations
and reality
Meaning of Eating2,3
„my daily bred give
me today“
Eating = life
Love Eating
Cultural & religious
differences
1: Calman KC. Quality of life in cancer patients-an hypothesis. J Med Ethics 1984; 10: 124-7
2: Mintz S.W et al, The Anthropology of food and eating, 2002
3: Salomonsson, Ethnologia Scaninavia 1990
Misunderstanding of „what happens with me“: hurts
New meaning and hope with less function & food
Florian Strasser ESPEN 2008
Cancer cachexia is defined by a negative energy
and protein balance driven by a variable
combination of reduced food intake and
hypermetabolism.
Over its course, cachexia is associated with
functional impairment.
A key defining feature is ongoing loss skeletal
muscle mass which is not fully reversed by
conventional nutritional support.
Cancer Cachexia (working) Definition
Clinical Cachexia Expert consensus,
ongoing Delphi procedure
Evans WJ et al.
Cachexia: A new
definition. Clin
Nutr 2008 Aug 19.
Florian Strasser ESPEN 2008
Limited life time implicating concurrent priorities
until death and likelihood to reach “nutritional” goals
Key aspects of Palliative Care in Cachexia 5/7
Time to response
days wks mts
Weight loss - survival
Loss of appetite
Nutritional intake
Body composition
- Edema
Function physical
Quality of life
- Fatigue (physical)
Eating-related Distress
Goals for cachexia treatment change of time
Florian Strasser ESPEN 2008
Current dilemmas in clinical decision making
Decisions to make: Pharmacological
Florian Strasser ESPEN 2008
Ed5.2 TPN example
Hoda D et al. (Mayo-Group), Cancer 2005;103:863
52 Pat., incurable, advanced cancer, 1979-99, Mayo
Retrospective review of Home-TPN
Indication:Bowel obstruction (n=20)
Shortbowel-Syndr., Malabsorption (n=16)
Fistula (n=11)
Dysmotility (n=3)
Nausea/vomiting, mucositis (n=2, n=1)
Anorexia (n=2)
Overall survival: 5 months (1-154)
Complications: 18 Infections, 4 Thrombosis, ..
Current dilemmas in clinical decision making
Decisions to make: „gut does not work“: TPN
Does gut really
not work???
Florian Strasser ESPEN 2008
Florian Strasser ESPEN 2008
Ed10.2 ERD
Goal-directed relieve of Eating-related Distress
A role for psycho-social-existential counseling?
Appetite Fluctuating, unpredictable, disgust
Inability to eat Predictable but dread of starving
Loss of weight Difficult to control, unpredictable
Eating Weight not linked
Insecurity What is healthy? Adaption, learning
Partnership Pressure, caring by food, innovative
Social contacts Limitations practical, „normal“
Professionals Not helpful advice, foresight
Weak/Death Fight a loosing battle ready to die
Strasser F et al. Eur Assoc. Pall Care, 2004
Florian Strasser ESPEN 2008
Nutrition: To do or not to do?
Nutritional counselling
Ravasco P et al. J Clin Oncol 2005; 23(7): e-pub
110 Patients colorectal-carzinoma radiotherapy
Group 1: „nutritional counselling“
Group 2: Oral protein-supplements
Group 3: Eat what you want
Effektive for calories and protein intake
Florian Strasser ESPEN 2008 Ravasco P et al. J Clin Oncol 2005; 23(7)
EBer Suppl Free
Nutr couns
Nutrition: To do or not to do?
Nutritional counselling: multidimensional care
Florian Strasser ESPEN 2008
- Estimate catabolic drive
- Inflammation: CRP <10 vs CRP >100, (PIF)
- Reversibility- Stabilization: when expected?
- Before start of TPN
- Agreement with patient and proxies when and
based on which criteria withdraw TPN
- Repeated evaluation if goals met and how tolerable
- after (1-) 2 – 4 weeks
- clinically, prealbumin, (transferrin)
- Safety: phosphat et al.
- Impact on quality-of-life
TPN yes or no
Multidimensional nutritional interventions
Increasing nutritional intake: Parenteral Nutrition